Secondary Logo

Journal Logo

In Response

Chen, Minshan PhD; Lai, Renchun MD

doi: 10.1213/ANE.0b013e31827a0afb
Letters to the Editor: Letters & Announcements
Free

Department of Hepatobiliary Surgery, Sun Yat-Sen University Cancer Center, chenmsh@sysucc.org.cn

Department of Anesthesiology, Sun Yat-Sen University Cancer Center, Guangzhou, People’s Rupublic of China

Back to Top | Article Outline

In Response

Grobmyer and Rice1 point out that regional anesthesia alone may not provide the best outcome from a surgical procedure for some cancer operations. We agree with them. However, we only had 6 patients with incomplete ablation. The difference in outcome is observed even when limited to complete ablations. Thus, difference in ablation success is not responsible for the observed differences.2 This issue of Anesthesia & Analgesia contains a small correction in an Erratum to better explain our patient selection. We now use continuous IV remifentanil anesthesia with or without propofol as our first choice for patients undergoing percutaneous radiofrequency ablation in our institution.

Minshan Chen, PhD

Department of Hepatobiliary Surgery

Sun Yat-Sen University Cancer Center

chenmsh@sysucc.org.cn

Renchun Lai, MD

Department of Anesthesiology

Sun Yat-Sen University Cancer Center

Guangzhou, People’s Rupublic of China

Back to Top | Article Outline

REFERENCES

1. Grobmyer SR, Rice MJ. . Is there an apparent reason for these cancer recurrence data? Anesth Analg. 2013;116:265
2. Lai R, Peng Z, Chen D, Wang X, Xing W, Zeng W, Chen M. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg. 2012;114:290–6
© 2013 International Anesthesia Research Society